Texas Oncology - Denton

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer1 trial
• Myelodysplastic syndromes1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• NSABP Foundation Inc1 trial
• Takeda1 trial

Running trials

• Recruiting

  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  NCT07422480· Phase 3· Takeda· Source

  Contact: Charles Kurkul (principal investigator)

• Active, not recruiting

  Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

  NCT05169567· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

  NCT03281954· Phase 3· NSABP Foundation Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myelodysplastic syndromes1 recruiting